BRPI0517245A - suspensão farmacêutica e de acetaminofeno isentas de corantes - Google Patents

suspensão farmacêutica e de acetaminofeno isentas de corantes

Info

Publication number
BRPI0517245A
BRPI0517245A BRPI0517245-4A BRPI0517245A BRPI0517245A BR PI0517245 A BRPI0517245 A BR PI0517245A BR PI0517245 A BRPI0517245 A BR PI0517245A BR PI0517245 A BRPI0517245 A BR PI0517245A
Authority
BR
Brazil
Prior art keywords
dye
suspension
free
effective amount
free pharmaceutical
Prior art date
Application number
BRPI0517245-4A
Other languages
English (en)
Inventor
Gail K Buehler
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of BRPI0517245A publication Critical patent/BRPI0517245A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

SUSPENSãO FARMACêUTICA E DE ACETAMINOFENO ISENTAS DE CORANTES. Uma suspensão farmacêutica isenta de corante tendo uma quantidade terapeuticamente eficaz de um primeiro agente ativo consistindo essencialmente em um primeiro agente ativo substancialmente insolúvel em água, uma quantidade eficaz de adoçante não-redutor; uma quantidade eficaz de água; e uma quantidade eficaz de um sistema de suspensão; em que a suspensão farmacêutica isenta de corante tem um pH de cerca de 5 a cerca de 6 e é substancialmente isenta de um açúcar redutor e métodos relacionados.
BRPI0517245-4A 2004-10-29 2005-10-27 suspensão farmacêutica e de acetaminofeno isentas de corantes BRPI0517245A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/978,035 US20060093631A1 (en) 2004-10-29 2004-10-29 Dye-free pharmaceutical suspensions and related methods
PCT/US2005/039348 WO2006050302A2 (en) 2004-10-29 2005-10-27 Dye-free pharmaceutical suspensions and related methods

Publications (1)

Publication Number Publication Date
BRPI0517245A true BRPI0517245A (pt) 2008-10-07

Family

ID=35712029

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0517245-4A BRPI0517245A (pt) 2004-10-29 2005-10-27 suspensão farmacêutica e de acetaminofeno isentas de corantes

Country Status (14)

Country Link
US (1) US20060093631A1 (pt)
EP (1) EP1809241B1 (pt)
JP (1) JP2008518948A (pt)
KR (1) KR101317657B1 (pt)
CN (1) CN101068530A (pt)
AR (1) AR051411A1 (pt)
AT (1) ATE518522T1 (pt)
BR (1) BRPI0517245A (pt)
CA (1) CA2585852C (pt)
ES (1) ES2368249T3 (pt)
MX (1) MX2007005207A (pt)
PL (1) PL1809241T3 (pt)
RU (1) RU2395275C2 (pt)
WO (1) WO2006050302A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US20080014275A1 (en) * 2006-07-13 2008-01-17 Buehler Gail K Pharmaceutical suspensions and related methods
US9006225B2 (en) * 2008-01-18 2015-04-14 Asahi Kasei Pharma Corporation Stable pharmaceutical composition
ES2569925T3 (es) 2009-09-30 2016-05-13 Acura Pharmaceuticals, Inc. Métodos y composiciones de disuasión del abuso
RU2673818C2 (ru) 2012-11-30 2018-11-30 Экьюра Фармасьютикалз, Инк. Саморегулируемое высвобождение фармацевтического ингредиента
US9642811B2 (en) 2014-03-26 2017-05-09 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release biphasic matrix solid dosage form
US11103581B2 (en) 2015-08-31 2021-08-31 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
GB2571937B (en) * 2018-03-12 2021-07-14 Syri Ltd Stable liquid suspension composition of fludrocortisone
CN112274483A (zh) * 2020-10-28 2021-01-29 河北冀衡药业股份有限公司 一种对乙酰氨基酚混悬滴剂及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485719A (en) * 1967-10-13 1969-12-23 Us Agriculture Continuous process for producing xanthomonas heteropolysaccharide
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids
GB8317696D0 (en) * 1983-06-29 1983-08-03 Shell Int Research Preparing xanthomonas heteroplysaccharide
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
US5112604A (en) * 1989-09-01 1992-05-12 Riker Laboratories, Inc. Oral suspension formulation
US5296241A (en) * 1991-04-03 1994-03-22 Brimberg Barnett J Therapeutic composition and method of using same for treatment of hangover
US5272137A (en) * 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
EP0620001A1 (en) * 1993-04-16 1994-10-19 McNEIL-PPC, INC. Aqueous pharmaceutical suspension and process for preparation thereof
AU7176994A (en) * 1993-06-25 1995-01-17 Ibah, Inc. Taste-masked acetaminophen suspensions and methods of making the same
EP0717992A3 (en) * 1994-12-21 1998-03-25 McNEIL-PPC, INC. Aqueous suspension formulations for pharmaceutical applications
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
IT1286496B1 (it) * 1996-11-20 1998-07-15 Leetrim Ltd Dublin Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
US6784326B1 (en) * 1998-06-17 2004-08-31 Cognis Corporation Process for improving stability of glycerin
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions

Also Published As

Publication number Publication date
AR051411A1 (es) 2007-01-10
EP1809241B1 (en) 2011-08-03
WO2006050302A2 (en) 2006-05-11
JP2008518948A (ja) 2008-06-05
EP1809241A2 (en) 2007-07-25
RU2395275C2 (ru) 2010-07-27
RU2007119722A (ru) 2008-12-10
CA2585852A1 (en) 2006-05-11
US20060093631A1 (en) 2006-05-04
MX2007005207A (es) 2007-11-08
PL1809241T3 (pl) 2012-01-31
ATE518522T1 (de) 2011-08-15
KR101317657B1 (ko) 2013-10-15
CN101068530A (zh) 2007-11-07
ES2368249T3 (es) 2011-11-15
WO2006050302A3 (en) 2007-02-15
KR20070085529A (ko) 2007-08-27
CA2585852C (en) 2013-06-25

Similar Documents

Publication Publication Date Title
BRPI0517245A (pt) suspensão farmacêutica e de acetaminofeno isentas de corantes
AR111695A2 (es) Suspensiones acuosas estabilizadas para administración parenteral
NO20015418L (no) Karboksylsyrederivater som hemmer binding av integriner til deres reseptorer
NO20076616L (no) 17beta-HSD1- og STS-inhibitorer
PE88699A1 (es) Formas de dosificacion de liberacion sostenida de sertralina
TR200101859T2 (tr) Kemokin alıcı aktivitesinin modülatörleri olarak N-üreidoalkil-piperidinler
AR020610A1 (es) Utilizacion de un copolimero de acido metacrilico de tipo c segun la farmacopea us national formulary usp/nf, como agente de desagregacion y el procedimiento de fabricaion de un comprimido con dicho copolimero
BR0313371A (pt) Composto, uso de um composto e método de tratamento de doença
NO20022989D0 (no) Middel som er anti-adhesivt i forhold til den patogene flora i huden
BR0014549A (pt) Artigo elástico
NO20005161L (no) N,N-disubstituerte amider som inhiberer bindingen av integriner til deres reseptorer
ES2189768T3 (es) Sintesis regioselectiva de derivados de rapamicina.
FI20011851A (fi) Fluoksetiinia tai sen happoadditiosuolaa sisältävä dispergoituva tabletti
CU23367A3 (es) Formulación de moxifloxacino con sal común
MY140676A (en) Structured body wash
NO20015419D0 (no) Propionsyrederivater som hemmer binding av integriner til deres reseptorer
MY139086A (en) Use of debranched starch in extrusion-spheronization pharmaceutical pellets
DK1401422T3 (da) Halogenholdig sammensætning, fremgangsmåde til fremstilling heraf og anvendelser heraf
ES2182507T3 (es) Sistema terapeutico que puede ser activado por la humedad.
AR051944A1 (es) Suspensiones farmaceuticas exentas de colorantes y metodos relacionados
HUP0302631A2 (hu) Stavudint tartalmazó elnyújtott hatóanyag-kibocsátású szemcsék
WO2002004409A3 (en) Tetrahydrobenzothiazole analogues as neuroprotective agents
BRPI0017528B8 (pt) uso de uma composição contendo sal de cetotifeno
BRPI0611526A2 (pt) composição tópica contendo gelatina
DK2018153T3 (da) Flydende orale sammensætninger

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B11T Dismissal of application maintained [chapter 11.20 patent gazette]